These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38514012)

  • 1. Clinical Significance of the Cystic Phenotype in Alport Syndrome.
    Zeni L; Mescia F; Toso D; Dordoni C; Mazza C; Savoldi G; Econimo L; Cortinovis R; Fisogni S; Alberici F; Scolari F; Izzi C
    Am J Kidney Dis; 2024 Sep; 84(3):320-328.e1. PubMed ID: 38514012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic phenotype and chronic kidney disease in autosomal dominant Alport syndrome.
    Bada-Bosch T; Sevillano AM; Sánchez-Calvin MT; Palma-Milla C; Alba de Cáceres I; Díaz-Crespo F; Trujillo H; Alonso M; Cases-Corona C; Shabaka A; Quesada-Espinosa JF; Lezana-Rosales JM; Gutiérrez E; Fernández-Juárez G; Caravaca-Fontán F; Praga M
    Nephrol Dial Transplant; 2024 Jul; 39(8):1288-1298. PubMed ID: 38178635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants.
    Furlano M; Pilco-Teran M; Pybus M; Martínez V; Aza-Carmona M; Rius Peris A; Pérez-Gomez V; Berná G; Mazon J; Hernández J; Fayos de Arizón L; Viera E; Gich I; Pérez HV; Gomá-Garcés E; Albero Dolon JL; Ars E; Torra R
    Nephrol Dial Transplant; 2024 Aug; 39(9):1442-1448. PubMed ID: 38317457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
    Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R
    Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report.
    Bhattacharyya A; Huang Y; Khan SH; Drachenberg CB; Malone LC
    BMC Nephrol; 2021 Oct; 22(1):358. PubMed ID: 34717572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review.
    Savige J; Harraka P
    Am J Kidney Dis; 2021 Dec; 78(6):857-864. PubMed ID: 34245817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.
    Gibson JT; Huang M; Shenelli Croos Dabrera M; Shukla K; Rothe H; Hilbert P; Deltas C; Storey H; Lipska-Ziętkiewicz BS; Chan MMY; Sadeghi-Alavijeh O; Gale DP; ; Cerkauskaite A; Savige J
    Sci Rep; 2022 Feb; 12(1):2722. PubMed ID: 35177655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.
    Yuan X; Su Q; Wang H; Shi S; Liu L; Lv J; Wang S; Zhu L; Zhang H
    J Am Soc Nephrol; 2023 Jan; 34(1):132-144. PubMed ID: 36130833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel
    Graziani L; Minotti C; Carriero ML; Bengala M; Lai S; Terracciano A; Novelli A; Novelli G
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence Estimates of Predicted Pathogenic
    Gibson J; Fieldhouse R; Chan MMY; Sadeghi-Alavijeh O; Burnett L; Izzi V; Persikov AV; Gale DP; Storey H; Savige J;
    J Am Soc Nephrol; 2021 Sep; 32(9):2273-2290. PubMed ID: 34400539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
    Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
    Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases.
    Bullich G; Domingo-Gallego A; Vargas I; Ruiz P; Lorente-Grandoso L; Furlano M; Fraga G; Madrid Á; Ariceta G; Borregán M; Piñero-Fernández JA; Rodríguez-Peña L; Ballesta-Martínez MJ; Llano-Rivas I; Meñica MA; Ballarín J; Torrents D; Torra R; Ars E
    Kidney Int; 2018 Aug; 94(2):363-371. PubMed ID: 29801666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare Collagenous Heterozygote Variants in Children With IgA Nephropathy.
    Cambier A; Robert T; Hogan J; Rabant M; Peuchmaur M; Boyer O; Ulinski T; Monteiro RC; Mesnard L
    Kidney Int Rep; 2021 May; 6(5):1326-1335. PubMed ID: 34013111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
    Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
    Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hematuria: A review.
    Plevová P; Gut J; Janda J
    Medicina (Kaunas); 2017; 53(1):1-10. PubMed ID: 28236514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.